GSK fires head of China research over data fraud
June 11, 2013Research and Development China, GSK, Jingwu Zang, MS, autoimmune
GlaxoSmithKline has dismissed its vice president of research in China in connection with ‘misrepresentation’ of research data.Jingwu Zang had been senior …
Charities invest £4.2m for London biosciences hub
June 11, 2013Research and Development, Sales and Marketing Biochemical Society, London hub, Society for General Microbiology, Society of Biology
A collective of five charitable societies have come together to create a new bioscience hub in central London. The offices …
Impax cuts staff at troubled California plant
June 11, 2013Manufacturing and Production FDA, Impax, Rytary
US generic drugmaker Impax Laboratories has said it plans to axe a tenth of its workforce and transfer production away …
Questcor hires Shire’s chief executive
June 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Questcor, Shire
Biopharma firm Questcor Pharmaceuticals has appointed the recently-retired chief executive of Shire to its Board of directors. Angus Russell …
Novartis works in MS switch
June 11, 2013Research and Development, Sales and Marketing MS, Novartis, gilenya
Novartis’ oral MS drug Gilenya has been found to help multiple sclerosis (MS) patients who switch to it after taking …
High cure rate for Boehringer HCV drug
June 11, 2013Research and Development, Sales and Marketing Boehringer Ingelheim, HCV
One of Boehringer Ingelheim’s pipeline drugs has achieved high response rates in patients with chronic genotype-1 hepatitis C virus (HCV) in …
AstraZeneca to pay up to $1.2 billion for Pearl
June 10, 2013Research and Development, Sales and Marketing AstraZeneca, COPD, pearl therapeutics
AstraZeneca is betting big on lung disease specialist Pearl Therapeutics as it looks to spend $1.2 billion to acquire the …
Manufacturing news in brief
June 10, 2013Manufacturing and Production Biological E Ltd, Hospira and Sotax Group, Schott Pharmaceutical Systems, Valneva SE
A round-up of recent developments in the pharma manufacturing sector, including facility updates from Valneva, Schott and Hospira, plus Sotax’s …
Department of Health prioritises Francis response
June 7, 2013Sales and Marketing DH, Francis, Mid Staffs, NHS
The Department of Health has set out its priorities for the next year, explaining how it will enhance public health …
Working Life, Vifor Pharma, Derek Williams
June 7, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vifor pharma, Working Life, williams
How did you find your way into your current role? I began my career in the UK as a sales …
NICE thumbs-up for Abilify
June 7, 2013Sales and Marketing Abilify, BMS, NICE, Otsuka
Adolescents who suffer from bipolar disorder should be treated on the NHS with Otsuka Pharmaceuticals’ Abilify, according to draft guidance …
Lilly UK sponsors ‘Go Dad Run’ charity
June 6, 2013Medical Communications go dad run, lilly, prostate
Lilly is sponsoring Olympic hurdler Colin Jackson’s ‘Go Dad Run’, a new 5k run for men to raise awareness of …
Internal buy-in is greatest barrier to social media
June 6, 2013Medical Communications Weber shandwick, digital, social media
Internal challenges – and not regulatory ones – are the biggest barriers to better use of social media in pharma, …
Boehringer unveils biopharma plant plan for China
June 6, 2013Manufacturing and Production Boehringer Ingelheim, China
Boehringer Ingelheim has said it intends to construct a cell-culture biopharmaceutical production facility in China offering contract R&D and manufacturing …
Novartis receives FDA warning
June 6, 2013Manufacturing and Production, Sales and Marketing CGMP, FDA, GMP, Novartis
The FDA has castigated Novartis for what it calls ‘significant violations’ of current good manufacturing practice (CGMP) regulations for finished …
PAN makes series of appointments and promotions
June 6, 2013Medical Communications Pan, agency, comms
Creative comms agency PAN has bolstered its team with two new arrivals and three promotions. Vanessa Hume has joined the …
Mirna appoints ex-Pfizer senior director
June 6, 2013Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, miRNA
Biotech firm Mirna Therapeutics has appointed Dr Sinil Kim as vice president of Oncology and chief medical officer. Kim will …
Bayer takes over Conceptus
June 6, 2013Sales and Marketing Bayer, Conceptus
The Bayer Group, which contains Bayer HealthCare, has taken over US contraception specialist Conceptus in a $1.1 billion deal. The …
Aveo to cut workforce after FDA knock-back
June 6, 2013Research and Development, Sales and Marketing Aveo, FDA, cuts, tivozanib
Aveo will make major jobs cuts this year after news that a kidney cancer licence for its oncology drug tivozanib …
J&J recalls 32 million contraceptive packs
June 5, 2013Manufacturing and Production Cilest, J&J, JJ, recall
Johnson & Johnson has announced a 43-country recall of its oral contraceptive Cilest and suspended production of the drug because …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
